Anavex Life Sciences Corp. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€37.09M -9.5% N/A -€26.58M +10.9% N/A
    €0.00 +NaN% -€40.98M -1.0% N/A -€23.97M +14.6% N/A
    €0.00 +NaN% -€41.39M +26.6% N/A -€20.91M -20.2% N/A
    €0.00 +NaN% -€32.70M +44.3% N/A -€26.21M +42.7% N/A
    €0.00 -100.0% -€22.67M -0.1% N/A -€18.36M +14.9% N/A
    -€590.87K -∞% -€22.68M +50.7% 3,838.7% +38 pp -€15.98M +47.2% 2,704.7% +27 pp
    €0.00 +NaN% -€15.05M +29.7% N/A -€10.85M +39.5% N/A
    €0.00 +NaN% -€11.61M -8.7% N/A -€7.78M -2.4% N/A
    €0.00 +NaN% -€12.71M +21.7% N/A -€7.97M +118.5% N/A
    €0.00 +NaN% -€10.44M +6.5% N/A -€3.65M +59.1% N/A
    €0.00 +NaN% -€9.81M +207.2% N/A -€2.29M +241.6% N/A
    €0.00 +NaN% -€3.19M -55.4% N/A -€670.73K -54.1% N/A
    €0.00 +NaN% -€7.16M +13.6% N/A -€1.46M -55.5% N/A
    €0.00 +NaN% -€6.30M -16.8% N/A -€3.28M -17.2% N/A
    €0.00 +NaN% -€7.58M +59.7% N/A -€3.96M +64.3% N/A
    €0.00 +NaN% -€4.74M +2.8% N/A -€2.41M +13.0% N/A
    €0.00 +NaN% -€4.62M +238.7% N/A -€2.13M +660.3% N/A
    €0.00 +NaN% -€1.36M +6,088.3% N/A -€280.56K +903.0% N/A
    €0.00 +NaN% -€22.02K -72.1% N/A -€27.97K -46.9% N/A
    €0.00 +NaN% -€79.03K +536.5% N/A -€52.68K +413.6% N/A
    €0.00 -€12.42K N/A -€10.26K N/A

    Notifications